Pathogenic effects of α-synuclein aggregation

Molecular Brain Research

Volumn 134, Issue 1, 2005, Pages 3-17

  Lundvig, Ditte ^a   Lindersson, Evo ^a   Jensen, Poul Henning ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Amyloid; Filaments; Lewy body; Lewy body dementia; Multiple systems atrophy; Neurodegeneration; Oligomers; Parkinson disease; Protein aggregation; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; FLUORESCENT DYE; LIPID; METAL; MONOMER; OLIGOMER; PESTICIDE; PROTEASOME; SERINE; UBIQUITIN;

ATOMIC FORCE MICROSCOPY; CELL TRANSPORT; CENTRIFUGATION; CIRCULAR DICHROISM; CONCENTRATION (PARAMETERS); FILTRATION; GEL FILTRATION; HOMEOSTASIS; HUMAN; IONIC STRENGTH; METHODOLOGY; MICROTUBULE; MISSENSE MUTATION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; TEMPERATURE; TRANSCRIPTION REGULATION; TRANSMISSION ELECTRON MICROSCOPY; TURBIDITY;

EID: 15544371311     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.09.001     Document Type: Review

References (127)

1. A. Abeliovich, Y. Schmitz, I. Farinas, D. Choi-Lundberg, W.H. Ho, P.E. Castillo, N. Shinsky, J.M. Verdugo, M. Armanini, A. Ryan, M. Hynes, H. Phillips, D. Sulzer, and A. Rosenthal Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system Neuron 25 2000 239 252
2. A. Agresti, and M.E. Bianchi HMGB proteins and gene expression Curr. Opin. Genet. Dev. 13 2003 170 178
3. M.A. Alim, M.S. Hossain, K. Arima, K. Takeda, Y. Izumiyama, M. Nakamura, H. Kaji, T. Shinoda, S. Hisanaga, and K. Ueda Tubulin seeds alpha-synuclein fibril formation J. Biol. Chem. 277 2002 2112 2117
4. S. Arawaka, Y. Saito, S. Murayama, and H. Mori Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein Neurology 51 1998 887 889
5. K. Arima, K. Ueda, N. Sunohara, K. Arakawa, S. Hirai, M. Nakamura, H. Tonozuka-Uehara, and M. Kawai NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy Acta Neuropathol. (Berl) 96 1998 439 444
6. K. Arima, K. Ueda, N. Sunohara, S. Hirai, Y. Izumiyama, H. Tonozuka-Uehara, and M. Kawai Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies Brain Res. 808 1998 93 100
7. K. Arima, S. Hirai, N. Sunohara, K. Aoto, Y. Izumiyama, K. Ueda, K. Ikeda, and M. Kawai Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies Brain Res. 843 1999 53 61
8. P.K. Auluck, H.Y. Chan, J.Q. Trojanowski, V.M. Lee, and N.M. Bonini Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease Science 295 2002 865 868
9. M. Baba, S. Nakajo, P.H. Tu, T. Tomita, K. Nakaya, V.M. Lee, J.Q. Trojanowski, and T. Iwatsubo Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies Am. J. Pathol. 152 1998 879 884
10. C.K. Bailey, I.F. Andriola, H.H. Kampinga, and D.E. Merry Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy Hum. Mol. Genet. 11 2002 515 523
11. N.F. Bence, R.M. Sampat, and R.R. Kopito Impairment of the ubiquitin-proteasome system by protein aggregation Science 292 2001 1552 1555
12. A.M. Bodles, D.J. Guthrie, B. Greer, and G.B. Irvine Identification of the region of non-Abeta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity J. Neurochem. 78 2001 384 395
13. D.E. Cabin, K. Shimazu, D. Murphy, N.B. Cole, W. Gottschalk, K.L. McIlwain, B. Orrison, A. Chen, C.E. Ellis, R. Paylor, B. Lu, and R.L. Nussbaum Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein J. Neurosci. 22 2002 8797 8807
14. S. Chandra, X. Chen, J. Rizo, R. Jahn, and T.C. Sudhof A broken alpha-helix in folded alpha-Synuclein J. Biol. Chem. 278 2003 15313 15318
15. K.K. Chung, V.L. Dawson, and T.M. Dawson The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders Trends Neurosci. 24 2001 S7 S14
16. N.B. Cole, D.D. Murphy, T. Grider, S. Rueter, D. Brasaemle, and R.L. Nussbaum Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein J. Biol. Chem. 277 2002 6344 6352
17. K.A. Conway, J.D. Harper, and P.T. Lansbury Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease Nat. Med. 4 1998 1318 1320
18. K.A. Conway, J.D. Harper, and P.T. Lansbury Jr. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid Biochemistry 39 2000 2552 2563
19. K.A. Conway, S.J. Lee, J.C. Rochet, T.T. Ding, R.E. Williamson, and P.T. Lansbury Jr. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc. Natl. Acad. Sci. U. S. A. 97 2000 571 576
20. K.A. Conway, J.C. Rochet, R.M. Bieganski, and P.T. Lansbury Jr. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct Science 294 2001 1346 1349
21. R.A. Crowther, R. Jakes, M.G. Spillantini, and M. Goedert Synthetic filaments assembled from C-terminally truncated alpha-synuclein FEBS Lett. 436 1998 309 312
22. J.G. Culvenor, C.A. McLean, S. Cutt, B.C. Campbell, F. Maher, P. Jakala, T. Hartmann, K. Beyreuther, C.L. Masters, and Q.X. Li Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid Am. J. Pathol. 155 1999 1173 1181
23. D.M. Cyr, J. Hohfeld, and C. Patterson Protein quality control: U-box-containing E3 ubiquitin ligases join the fold Trends Biochem. Sci. 27 2002 368 375
24. W.S. Davidson, A. Jonas, D.F. Clayton, and J.M. George Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes J. Biol. Chem. 273 1998 9443 9449
25. D.W. Dickson, W. Liu, J. Hardy, M. Farrer, N. Mehta, R. Uitti, M. Mark, T. Zimmerman, L. Golbe, J. Sage, A. Sima, D'C. Amato, R. Albin, S. Gilman, and S.H. Yen Widespread alterations of alpha-synuclein in multiple system atrophy Am. J. Pathol. 155 1999 1241 1251
26. T.T. Ding, S.J. Lee, J.C. Rochet, and P.T. Lansbury Jr. Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes Biochemistry 41 2002 10209 10217
27. J.E. Duda, B.I. Giasson, Q. Chen, T.L. Gur, H.I. Hurtig, M.B. Stern, S.M. Gollomp, H. Ischiropoulos, V.M. Lee, and J.Q. Trojanowski Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies Am. J. Pathol. 157 2000 1439 1445
28. O.M. El Agnaf, R. Jakes, M.D. Curran, and A. Wallace Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease FEBS Lett. 440 1998 67 70
29. O.M. El Agnaf, R. Jakes, M.D. Curran, D. Middleton, R. Ingenito, E. Bianchi, A. Pessi, D. Neill, and A. Wallace Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments FEBS Lett. 440 1998 71 75
30. M. Farrer, J. Kachergus, L. Forno, S. Lincoln, D.S. Wang, M. Hulihan, D. Maraganore, K. Gwinn-Hardy, Z. Wszolek, D. Dickson, and J.W. Langston Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications Ann. Neurol. 55 2004 174 179
31. M.B. Feany, and W.W. Bender A Drosophila model of Parkinson's disease Nature 404 2000 394 398
32. L.S. Forno Neuropathology of Parkinson's disease J. Neuropathol. Exp. Neurol. 55 1996 259 272
33. H. Fujiwara, M. Hasegawa, N. Dohmae, A. Kawashima, E. Masliah, M.S. Goldberg, J. Shen, K. Takio, and T. Iwatsubo Alpha-Synuclein is phosphorylated in synucleinopathy lesions Nat. Cell Biol. 4 2002 160 164
34. W.P. Gai, J.H. Power, P.C. Blumbergs, and W.W. Blessing Multiple-system atrophy: a new alpha-synuclein disease? Lancet 352 1998 547 548
35. W.P. Gai, J.H. Power, P.C. Blumbergs, J.G. Culvenor, and P.H. Jensen Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components J. Neurochem. 73 1999 2093 2100
36. W.P. Gai, D.L. Pountney, J.H. Power, Q.X. Li, J.G. Culvenor, C.A. McLean, P.H. Jensen, and P.C. Blumbergs Alpha-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy Exp. Neurol. 181 2003 68 78
37. J.M. George, H. Jin, W.S. Woods, and D.F. Clayton Characterization of a novel protein regulated during the critical period for song learning in the zebra finch Neuron 15 1995 361 372
38. B.I. Giasson, K. Uryu, J.Q. Trojanowski, and V.M. Lee Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro J. Biol. Chem. 274 1999 7619 7622
39. B.I. Giasson, J.E. Duda, I.V. Murray, Q. Chen, J.M. Souza, H.I. Hurtig, H. Ischiropoulos, J.Q. Trojanowski, and V.M. Lee Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions Science 290 2000 985 989
40. B.I. Giasson, I.V. Murray, J.Q. Trojanowski, and V.M. Lee A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly J. Biol. Chem. 276 2001 2380 2386
41. B.I. Giasson, J.E. Duda, S.M. Quinn, B. Zhang, J.Q. Trojanowski, and V.M. Lee Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein Neuron 34 2002 521 533
42. B.I. Giasson, M.S. Forman, M. Higuchi, L.I. Golbe, C.L. Graves, P.T. Kotzbauer, J.Q. Trojanowski, and V.M. Lee Initiation and synergistic fibrillization of tau and alpha-synuclein Science 300 2003 636 640
43. J. Goers, A.B. Manning-Bog, A.L. McCormack, I.S. Millett, S. Doniach, D.A. Di Monte, V.N. Uversky, and A.L. Fink Nuclear localization of alpha-synuclein and its interaction with histones Biochemistry 42 2003 8465 8471
44. N. Golts, H. Snyder, M. Frasier, C. Theisler, P. Choi, and B. Wolozin Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein J. Biol. Chem. 277 2002 16116 16123
45. J.D. Harper, and P.T. Lansbury Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66 1997 385 407
46. M. Hashimoto, L.J. Hsu, A. Sisk, Y. Xia, A. Takeda, M. Sundsmo, and E. Masliah Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease Brain Res. 799 1998 301 306
47. M. Hashimoto, L.J. Hsu, Y. Xia, A. Takeda, A. Sisk, M. Sundsmo, and E. Masliah Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro NeuroReport 10 1999 717 721
48. M. Hashimoto, A. Takeda, L.J. Hsu, T. Takenouchi, and E. Masliah Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease J. Biol. Chem. 274 1999 28849 28852
49. M. Hashimoto, E. Rockenstein, M. Mante, M. Mallory, and E. Masliah beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor Neuron 32 2001 213 223
50. V. Heiser, E. Scherzinger, A. Boeddrich, E. Nordhoff, R. Lurz, N. Schugardt, H. Lehrach, and E.E. Wanker Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy Proc. Natl. Acad. Sci. U. S. A. 97 2000 6739 6744
51. W. Hoyer, T. Antony, D. Cherny, G. Heim, T.M. Jovin, and V. Subramaniam Dependence of alpha-synuclein aggregate morphology on solution conditions J. Mol. Biol. 322 2002 383 393
52. K. Ii, H. Ito, K. Tanaka, and A. Hirano Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly J. Neuropathol. Exp. Neurol. 56 1997 125 131
53. A. Iwai, E. Masliah, M. Yoshimoto, N. Ge, L. Flanagan, H.A. de Silva, A. Kittel, and T. Saitoh The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system Neuron 14 1995 467 475
54. A. Iwata, S. Miura, I. Kanazawa, M. Sawada, and N. Nukina Alpha-Synuclein forms a complex with transcription factor Elk-1 J. Neurochem. 77 2001 239 252
55. R. Jakes, M.G. Spillantini, and M. Goedert Identification of two distinct synucleins from human brain FEBS Lett. 345 1994 27 32
56. P.H. Jensen, K. Islam, J. Kenney, M.S. Nielsen, J. Power, and W.P. Gai Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments J. Biol. Chem. 275 2000 21500 21507
57. E. Jo, J. McLaurin, C.M. Yip, P. George-Hyslop, and P.E. Fraser Alpha-Synuclein membrane interactions and lipid specificity J. Biol. Chem. 275 2000 34328 34334
58. P.J. Kahle, M. Neumann, L. Ozmen, V. Muller, H. Jacobsen, A. Schindzielorz, M. Okochi, U. Leimer, P.H. van Der, A. Probst, E. Kremmer, H.A. Kretzschmar, and C. Haass Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain J. Neurosci. 20 2000 6365 6373
59. P.J. Kahle, M. Neumann, L. Ozmen, V. Muller, S. Odoy, N. Okamoto, H. Jacobsen, T. Iwatsubo, J.Q. Trojanowski, H. Takahashi, K. Wakabayashi, N. Bogdanovic, P. Riederer, H.A. Kretzschmar, and C. Haass Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model Am. J. Pathol. 159 2001 2215 2225
60. P.J. Kahle, M. Neumann, L. Ozmen, V. Muller, H. Jacobsen, W. Spooren, B. Fuss, B. Mallon, W.B. Macklin, H. Fujiwara, M. Hasegawa, T. Iwatsubo, H.A. Kretzschmar, and C. Haass Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes EMBO Rep. 3 2002 583 588
61. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
62. S. Keck, R. Nitsch, T. Grune, and O. Ullrich Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease J. Neurochem. 85 2003 115 122
63. D. Kirik, C. Rosenblad, C. Burger, C. Lundberg, T.E. Johansen, N. Muzyczka, R.J. Mandel, and A. Bjorklund Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system J. Neurosci. 22 2002 2780 2791
64. J. Klucken, Y. Shin, E. Masliah, B.T. Hyman, and P.J. McLean Hsp70 Reduces alpha-Synuclein Aggregation and Toxicity J. Biol. Chem. 279 2004 25497 25502
65. R. Kruger, W. Kuhn, T. Muller, D. Woitalla, M. Graeber, S. Kosel, H. Przuntek, J.T. Epplen, L. Schols, and O. Riess Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat. Genet. 18 1998 106 108
66. H.A. Lashuel, D. Hartley, B.M. Petre, T. Walz, and P.T. Lansbury Jr. Neurodegenerative disease: amyloid pores from pathogenic mutations Nature 418 2002 291
67. H.A. Lashuel, B.M. Petre, J. Wall, M. Simon, R.J. Nowak, T. Walz, and P.T. Lansbury Jr. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils J. Mol. Biol. 322 2002 1089 1102
68. M.K. Lee, W. Stirling, Y. Xu, X. Xu, D. Qui, A.S. Mandir, T.M. Dawson, N.G. Copeland, N.A. Jenkins, and D.L. Price Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 →Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice Proc. Natl. Acad. Sci. U. S. A. 99 2002 8968 8973
69. W.L. Lin, M.W. DeLucia, and D.W. Dickson Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy Neurosci. Lett. 354 2004 99 102
70. E. Lindersson, and P.H. Jensen Alpha-synuclein binding proteins P.J. Kahle C. Haass Molecular Mechanisms of Parkinson's Disease, Landes Bioscience 2004 1 12
71. E. Lindersson, R. Beedholm, P. Hojrup, T. Moos, W. Gai, K.B. Hendil, and P.H. Jensen Proteasomal inhibition by alpha-synuclein filaments and oligomers J. Biol. Chem. 279 2004 12924 12934
72. E. Lindersson, P. Højrup, W. Gai, D. Locker, D. Martin, and P.H. Jensen Alpha-synuclein filaments bind the transcriptional regulator HMGB-1 Manus 2004 (submitted for publication)
73. E. Lindersson, D. Lundvig, C. Petersen, P. Madsen, J.R. Nyengaard, P. Højrup, T. Moos, D. Otzen, W. Gai, P.C. Blumbergs, and P.H. Jensen p25alpha stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies Manus 2004 (submitted for publication)
74. H. Lodish, A. Berk, S.L. Zipursky, P. Matsudaira, D. Baltimore, and J. Darnell Mol. Cell. Biol. 1999 85 87
75. A.B. Manning-Bog, A.L. McCormack, J. Li, V.N. Uversky, A.L. Fink, and D.A. Di Monte The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein J. Biol. Chem. 277 2002 1641 1644
76. E. Masliah, E. Rockenstein, I. Veinbergs, M. Mallory, M. Hashimoto, A. Takeda, Y. Sagara, A. Sisk, and L. Mucke Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders Science 287 2000 1265 1269
77. K.S. McNaught, and P. Jenner Proteasomal function is impaired in substantia nigra in Parkinson's disease Neurosci. Lett. 297 2001 191 194
78. K.S. McNaught, R. Belizaire, O. Isacson, P. Jenner, and C.W. Olanow Altered proteasomal function in sporadic Parkinson's disease Exp. Neurol. 179 2003 38 46
79. H. Miake, H. Mizusawa, T. Iwatsubo, and M. Hasegawa Biochemical characterization of the core structure of alpha-synuclein filaments J. Biol. Chem. 277 2002 19213 19219
80. D.D. Murphy, S.M. Rueter, J.Q. Trojanowski, and V.M. Lee Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons J. Neurosci. 20 2000 3214 3220
81. I.V. Murray, B.I. Giasson, S.M. Quinn, V. Koppaka, P.H. Axelsen, H. Ischiropoulos, J.Q. Trojanowski, and V.M. Lee Role of alpha-synuclein carboxy-terminus on fibril formation in vitro Biochemistry 42 2003 8530 8540
82. L. Narhi, S.J. Wood, S. Steavenson, Y. Jiang, G.M. Wu, D. Anafi, S.A. Kaufman, F. Martin, K. Sitney, P. Denis, J.C. Louis, J. Wypych, A.L. Biere, and M. Citron Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation J. Biol. Chem. 274 1999 9843 9846
83. M. Necula, C.N. Chirita, and J. Kuret Rapid anionic micelle-mediated alpha-synuclein fibrillization in vitro J. Biol. Chem. 278 2003 46674 46680
84. M.S. Nielsen, H. Vorum, E. Lindersson, and P.H. Jensen Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization J. Biol. Chem. 276 2001 22680 22684
85. M. Nishie, F. Mori, H. Fujiwara, M. Hasegawa, M. Yoshimoto, T. Iwatsubo, H. Takahashi, and K. Wakabayashi Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy Acta Neuropathol. (Berl) 107 2004 292 298
86. N. Ostrerova-Golts, L. Petrucelli, J. Hardy, J.M. Lee, M. Farer, and B. Wolozin The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity J. Neurosci. 20 2000 6048 6054
87. S.R. Paik, J.H. Lee, D.H. Kim, C.S. Chang, and J. Kim Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid Arch. Biochem. Biophys. 344 1997 325 334
88. S.R. Paik, H.J. Shin, J.H. Lee, C.S. Chang, and J. Kim Copper(II)-induced self-oligomerization of alpha-synuclein Biochem. J. 340 Pt 3 1999 821 828
89. M.I. Papp, J.E. Kahn, and P.L. Lantos Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) J. Neurol. Sci. 94 1989 79 100
90. J.E. Payton, R.J. Perrin, D.F. Clayton, and J.M. George Protein-protein interactions of alpha-synuclein in brain homogenates and transfected cells Brain Res. Mol. Brain Res. 95 2001 138 145
91. R.J. Perrin, W.S. Woods, D.F. Clayton, and J.M. George Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins J. Biol. Chem. 276 2001 41958 41962
92. L. Pirkkala, T.P. Alastalo, X. Zuo, I.J. Benjamin, and L. Sistonen Disruption of heat shock factor 1 reveals an essential role in the ubiquitin proteolytic pathway Mol. Cell. Biol. 20 2000 2670 2675
93. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
94. D.L. Pountney, R. Lowe, M. Quilty, J.C. Vickers, N.H. Voelcker, and W.P. Gai Annular alpha-synuclein species from purified multiple system atrophy inclusions J. Neurochem. 90 2004 502 512
95. Y. Saito, A. Kawashima, N.N. Ruberu, H. Fujiwara, S. Koyama, M. Sawabe, T. Arai, H. Nagura, H. Yamanouchi, M. Hasegawa, T. Iwatsubo, and S. Murayama Accumulation of phosphorylated alpha-synuclein in aging human brain J. Neuropathol. Exp. Neurol. 62 2003 644 654
96. L.C. Serpell, J. Berriman, R. Jakes, M. Goedert, and R.A. Crowther Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation Proc. Natl. Acad. Sci. U. S. A. 97 2000 4897 4902
97. R. Sharon, I. Bar-Joseph, M.P. Frosch, D.M. Walsh, J.A. Hamilton, and D.J. Selkoe The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease Neuron 37 2003 583 595
98. M.D. Shtilerman, T.T. Ding, and P.T. Lansbury Jr. Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease? Biochemistry 41 2002 3855 3860
99. A. Singleton, K. Gwinn-Hardy, Y. Sharabi, S.T. Li, C. Holmes, R. Dendi, J. Hardy, A. Singleton, A. Crawley, and D.S. Goldstein Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication Brain 127 2004 768 772
100. M.A. Sirover New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase Biochim. Biophys. Acta 1432 1999 159 184
101. H. Snyder, K. Mensah, C. Theisler, J. Lee, A. Matouschek, and B. Wolozin Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function J. Biol. Chem. 278 2003 11753 11759
102. J.M. Souza, B.I. Giasson, Q. Chen, V.M. Lee, and H. Ischiropoulos Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies J. Biol. Chem. 275 2000 18344 18349
103. M.G. Spillantini, M.L. Schmidt, V.M. Lee, J.Q. Trojanowski, R. Jakes, and M. Goedert Alpha-synuclein in Lewy bodies Nature 388 1997 839 840
104. M.G. Spillantini, R.A. Crowther, R. Jakes, N.J. Cairns, P.L. Lantos, and M. Goedert Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies Neurosci. Lett. 251 1998 205 208
105. M.G. Spillantini, R.A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies Proc. Natl. Acad. Sci. U. S. A. 95 1998 6469 6473
106. M. Takahashi, K. Tomizawa, S.C. Fujita, K. Sato, T. Uchida, and K. Imahori A brain-specific protein p25 is localized and associated with oligodendrocytes, neuropil, and fiber-like structures of the CA3 hippocampal region in the rat brain J. Neurochem. 60 1993 228 235
107. M. Takahashi, H. Kanuka, H. Fujiwara, A. Koyama, M. Hasegawa, M. Miura, and T. Iwatsubo Phosphorylation of alpha-synuclein characteristic of synucleinopathy lesions is recapitulated in alpha-synuclein transgenic Drosophila Neurosci. Lett. 336 2003 155 158
108. N.A. Tatton Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease Exp. Neurol. 166 2000 29 43
109. T. Togo, E. Iseki, W. Marui, H. Akiyama, K. Ueda, and K. Kosaka Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies J. Neurol. Sci. 184 2001 71 75
110. P.H. Tu, J.E. Galvin, M. Baba, B. Giasson, T. Tomita, S. Leight, S. Nakajo, T. Iwatsubo, J.Q. Trojanowski, and V.M. Lee Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein Ann. Neurol. 44 1998 415 422
111. K. Ueda, H. Fukushima, E. Masliah, Y. Xia, A. Iwai, M. Yoshimoto, D.A. Otero, J. Kondo, Y. Ihara, and T. Saitoh Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 90 1993 11282 11286
112. T. Ushiki, J. Hitomi, S. Ogura, T. Umemoto, and M. Shigeno Atomic force microscopy in histology and cytology Arch. Histol. Cytol. 59 1996 421 431
113. V.N. Uversky, J. Li, and A.L. Fink Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure J. Biol. Chem. 276 2001 44284 44296
114. V.N. Uversky, J. Li, and A.L. Fink Evidence for a partially folded intermediate in alpha-synuclein fibril formation J. Biol. Chem. 276 2001 10737 10744
115. V.N. Uversky, J. Li, and A.L. Fink Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease FEBS Lett. 500 2001 105 108
116. V.N. Uversky, M. Cooper, K.S. Bower, J. Li, and A.L. Fink Accelerated alpha-synuclein fibrillation in crowded milieu FEBS Lett. 515 2002 99 103
117. V.N. Uversky, J. Li, P. Souillac, I.S. Millett, S. Doniach, R. Jakes, M. Goedert, and A.L. Fink Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins J. Biol. Chem. 277 2002 11970 11978
118. V.N. Uversky, G. Yamin, P.O. Souillac, J. Goers, C.B. Glaser, and A.L. Fink Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro FEBS Lett. 517 2002 239 244
119. P.H. van Der, K.H. Wiederhold, A. Probst, S. Barbieri, C. Mistl, S. Danner, S. Kauffmann, K. Hofele, W.P. Spooren, M.A. Ruegg, S. Lin, P. Caroni, B. Sommer, M. Tolnay, and G. Bilbe Neuropathology in mice expressing human alpha-synuclein J. Neurosci. 20 2000 6021 6029
120. M.J. Volles, and P.T. Lansbury Jr. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism Biochemistry 41 2002 4595 4602
121. M.J. Volles, S.J. Lee, J.C. Rochet, M.D. Shtilerman, T.T. Ding, J.C. Kessler, and P.T. Lansbury Jr. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease Biochemistry 40 2001 7812 7819
122. K. Wakabayashi, K. Matsumoto, K. Takayama, M. Yoshimoto, and H. Takahashi NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease Neurosci. Lett. 239 1997 45 48
123. K. Wakabayashi, M. Yoshimoto, S. Tsuji, and H. Takahashi Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy Neurosci. Lett. 249 1998 180 182
124. P.H. Weinreb, W. Zhen, A.W. Poon, K.A. Conway, and P.T. Lansbury Jr. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded Biochemistry 35 1996 13709 13715
125. S.J. Wood, J. Wypych, S. Steavenson, J.C. Louis, M. Citron, and A.L. Biere Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease J. Biol. Chem. 274 1999 19509 19512
126. G. Yamin, V.N. Uversky, and A.L. Fink Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers FEBS Lett. 542 2003 147 152
127. J.J. Zarranz, J. Alegre, J.C. Gomez-Esteban, E. Lezcano, R. Ros, I. Ampuero, L. Vidal, J. Hoenicka, O. Rodriguez, B. Atares, V. Llorens, T.E. Gomez, T. del Ser, D.G. Munoz, and J.G. de Yebenes The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann. Neurol. 55 2004 164 173